Impact of sarcopenia on the prognosis of patients with advanced non‐small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis
Patients with advanced NSCLC with comorbid sarcopenia exhibit a worse prognosis when treated with antiangiogenic therapy, and preventing and ameliorating sarcopenia may lead to better survival outcomes in patients with advanced NSCLC.
Authors
- Jialin Zhang (ORCID: https://orcid.org/0000-0003-2617-2735)
- Hui Zhao (ORCID: https://orcid.org/0000-0002-1988-0197)
- Fuchun Huang (ORCID: https://orcid.org/0000-0002-8860-0451)
- Liu Hua
- Shuang Yang
- Mingxuan Ma
- Liye Lang
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1111/1759-7714.15443
- Citations
- 3
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.98
Funders
- National Natural Science Foundation of China